Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial

Alexander Olawaiye, Laurence Gladieff, David M. O’Malley, Jae‐Weon Kim, Gabriel Garbaos, Vanda Salutari, Lucy Gilbert, Linda Mileshkin, Alix Devaux, Elizabeth Hopp, Yong Jae Lee, Ana Oaknin, Mariana Scaranti, Byoung-Gie Kim, Nicoletta Colombo, Michael McCollum, Connie I. Diakos, Andrew R. Clamp, Aliza Leiser, Boglárka Balázs, Bradley J. Monk, Giuseppa Scandurra, C. McClung, Emilie Kaczmarek, Brian M. Slomovitz, Helena de la Cueva, Aknar Calabrich, Chiara Cassani, Benoît You, Toon Van Gorp, Cristina Churruca, Giuseppe Luigi Banna, Shibani Nicum, Andrea Bagaméri, Grazia Artioli, Lubomir Bodnar, Sokbom Kang, Ignace Vergote, Amanda Kesner-Hays, Hristina I. Pashova, Sachin Gopalkrishna Pai, Iulia Cristina Tudor, Adrian M. Jubb, Domenica Lorusso